Big Pharma — enzymatic production of chemicals

EMBLEM and Enzymicals AG announce a license and collaboration agreement to improve enzymatic production of chemicals Heidelberg & Greifswald (Germany), February 2021 – EMBLEM Technology Transfer GmbH and Enzymicals AG enter into a partnership on the use of innovative computational tools to feed the company’s product pipeline. EMBLEM Technology Transfer GmbH, the exclusive technology transfer partner of the European Molecular Biology Laboratory (EMBL), Europe’s flagship laboratory in the life sciences, and Enzymicals AG, a German enterprise focusing on industrial biocatalysis, today announce a non-exclusive license and collaboration. The parties will leverage Transform-MinER, a novel in silico tool package developed at...